IDV vehicle
36E79722D0015
NEW AWARD FOR VARDENAFIL HCL TABLETS WITH AVKARE. PERFORMANCE PERIOD IS AUGUST 7, 2022 - AUGUST 6, 2023 WITH FOUR ONE-YEAR OPTIONS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NAC PHARMACEUTICALS (36E797) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $7.8M |
| Start date | Aug 7, 2022 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Sep 10, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 12 of 12 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 10, 2026 | P00011 | $0 | INCORPORATE DEI CLAUSE 52.222-90 |
| Jul 9, 2026 | P00010 | $0 | EXERCISE OPTION 4 WITH NO PRICE CHANGES |
| Dec 16, 2025 | P00009 | $0 | ADDING 2026 SUBCONTRACTING PLAN |
| Aug 6, 2025 | P00008 | $0 | EXERCISE OPTION YEAR 3 FOR VARDENAFIL WITH NO PRICE CHANGES |
| Jan 6, 2025 | P00007 | $0 | 2025 SUBCONTRACTING PLAN |
| Jul 12, 2024 | P00006 | $0 | VARDENAFIL OPTION 2 |
| Mar 13, 2024 | P00005 | $0 | CRF REPORTING AND SALES SUBMITTAL PROCESS UPDATE |
| Dec 14, 2023 | P00004 | $0 | AVKARE 2024 SUBCONTRACTING PLAN |
| Jul 7, 2023 | P00003 | $0 | EXERCISE VARDENAFIL OPTION 1, NO PRICE CHANGES. PERIOD OF PERFORMANCE IS 8/7/2023 - 8/6/2024. |
| May 15, 2023 | P00002 | $0 | INCORPORATE 2023 LANGUAGE |
| Dec 15, 2022 | P00001 | $0 | INCORPORATE 2023 SUBCONTRACTING PLAN |
| Jun 8, 2022 | 0 | $0 | NEW AWARD FOR VARDENAFIL HCL TABLETS WITH AVKARE. PERFORMANCE PERIOD IS AUGUST 7, 2022 - AUGUST 6, 2023 WITH FOUR ONE-YEAR OPTIONS |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.